1
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, December 5, 1995: US05472943 (131 worldwide citation)

This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side-effects caused by the chronic administratio ...


2
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, August 1, 2000: US06096756 (124 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


3
Stanley M Crain, Ke Fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, April 30, 1996: US05512578 (101 worldwide citation)

This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side effects caused by the chronic administratio ...


4
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, December 3, 1996: US05580876 (95 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


5
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University, Amster Rothstein & Ebenstein, June 16, 1998: US05767125 (91 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


6
Stanley M Crain, Ke fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, April 11, 2006: US07026329 (32 worldwide citation)

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


7
Stanley M Crain, Ke Fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists. Albert Einstein College of Medicine of Yeshiva University, Amster Rothstein & Ebenstein, February 1, 2000: USRE036547

This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side effects caused by the chronic administratio ...


8
Crain Stanley M, Shen Ke Fei: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists. Einstein Coll Med, November 26, 1997: EP0808165-A1

This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side effects caused by the chronic administratio ...


9
Stanley M Crain, Ke Fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Craig J Arnold, Amster Rothstein & Ebenstein, July 18, 2002: US20020094947-A1

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...


10
Stanley M Crain, Ke Fei Shen: Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists. Craig J Arnold, Amster Rothstein & Ebenstein, December 18, 2003: US20030232744-A1

This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of ...